Cardiac evaluation of liver transplant candidates

World Journal of Gastroenterology

Volumn 14, Issue 22, 2008, Pages 3445-3451

  Mandell, Mercedes Susan ^a   Lindenfeld, JoAnn ^a   Tsou, Mei Yung ^b   Zimmerman, Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiac electrophysiology liver transplantation; Cardiomyopathy; Cirrhosis; Coronary artery disease; Coronary atherosclerosis; Echocardiography

Indexed keywords

CALCIUM; DOBUTAMINE;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL EXAMINATION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY OBSTRUCTION; DEATH; ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART PERFORMANCE; HEART SCINTISCANNING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOXEMIA; ISCHEMIC HEART DISEASE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG EDEMA; PATIENT SELECTION; PREOPERATIVE EVALUATION; PREVALENCE; PROGNOSIS; QT INTERVAL; RESTRICTIVE CARDIOMYOPATHY;

EID: 54349098037     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3445     Document Type: Editorial

References (62)

1. Turner TB, Bennett VL, Hernandez H. The beneficial side of moderate alcohol use. Johns Hopkins Med J 1981; 148: 53-63
2. Snowden CP, Hughes T, Rose J, Roberts DR. Pulmonary edema in patients after liver transplantation. Liver Transpl 2000; 6: 466-470
3. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, Armstrong WF. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 1180-1188
4. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999; 82: 265-268
5. Nagoshi T, Koiwaya Y, Doi H, Eto T. Angiographic coronary morphology in patients with ischemic heart disease. J Cardiol 2000; 36: 91-102
6. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, Vogt DP, Mayes JT, Westveer MK, Easley KA. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59: 859-864
7. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 426-430
8. Morris JJ, Hellman CL, Gawey BJ, Ramsay MA, Valek TR, Gunning TC, Swygert TH, Shore-Lesserson L, Lalehzarian F, Brayman KL. Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vasc Anesth 1995; 9: 322-332
9. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, Flamm S, Davidson CJ, Gheorghiade M. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006; 98: 178-181
10. United Network for Organ Sharing Organ Procurement: Available at The U.S. Transplant Network/Scientific Registry of Transplant Recipients 2006 Annual report: Transplant data. Available from: URL: http://www.ustransplant.org/annual_reports/current/survival_rates.htm
11. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152: 983-990
12. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005; 173: 627-634
13. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323: 1781-1788
14. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542-553
15. Welten GM, Schouten O, van Domburg RT, Feringa HH, Hoeks SE, Dunkelgrun M, van Gestel YR, Goei D, Bax JJ, Poldermans D. The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg 2007; 34: 632-638
16. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, van De Ven LL, van Urk H, Roelandt JR. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001; 285: 1865-1873
17. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180-189
18. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191: 235-240
19. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007; 46: 1126-1132
20. London RM, George J. Pathogenesis of NASH: animal models. Clin Liver Dis 2007; 11: 55-74, viii
21. Kryzhanovski VA, Beller GA. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation. Am J Cardiol 1997; 79: 986-988
22. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108: 1541-1545
23. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995; 92: 2157-2162
24. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003; 228: 826-833
25. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000; 36: 326-340
26. Ramakrishna G, Breen JF, Mulvagh SL, McCully RB, Pellikka PA. Relationship between coronary artery calcification detected by electron-beam computed tomography and abnormal stress echocardiography: association and prognostic implications. J Am Coll Cardiol 2006; 48: 2125-2131
27. Berman DS, Wong ND, Gransar H, Miranda-Peats R, Dahlbeck J, Hayes SW, Friedman JD, Kang X, Polk D, Hachamovitch R, Shaw L, Rozanski A. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 2004; 44: 923-930
28. Anand DV, Lim E, Raval U, Lipkin D, Lahiri A. Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography. J Nucl Cardiol 2004; 11: 450-457
29. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004; 43: 1663-1669
30. Nasir K, Shaw LJ, Liu ST, Weinstein SR, Mosler TR, Flores PR, Flores FR, Raggi P, Berman DS, Blumenthal RS, Budoff MJ. Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol 2007; 50: 953-960
31. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003; 107: 2571-2576
32. Cheng VY, Lepor NE, Madvoon H, Eshaghian S, Naraghi AL, Shah PK. Presence and severity of noncalcified coronary plaque on 64-slice computed tomographic coronary angiography in patients with zero and low coronary artery calcium. Am J Cardiol 2007; 99: 1183-1186
33. Loong CY, Anagnostopoulos C. Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging. Heart 2004; 90 Suppl 5: v2-v9
34. Geleijnse ML, Krenning BJ, Nemes A, Soliman OI, Galema TW, ten Cate FJ. Diagnostic value of dobutamine stress echocardiography in patients with normal wall motion at rest. Echocardiography 2007; 24: 553-557
35. Paetsch I, Jahnke C, Wahl A, Gebker R, Neuss M, Fleck E, Nagel E. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004; 110: 835-842
36. Tsutsui JM, Mukherjee S, Elhendy A, Xie F, Lyden ER, O'Leary E, McGrain AC, Porter TR. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl 2006; 12: 592-599
37. Zoghbi GJ, Patel AD, Ershadi RE, Heo J, Bynon JS, Iskandrian AE. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol 2003; 92: 1066-1071
38. Guckelberger O, Byram A, Klupp J, Neumann UP, Glanemann M, Stockmann M, Neuhaus R, Neuhaus P. Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors. Transpl Int 2005; 18: 967-974
39. Nagarakanti R, Whellan D, Rubin S, Mather PJ. Reversible cardiomyopathies. Cardiol Rev 2007; 15: 178-183
40. Torregrosa M, Aguade S, Dos L, Segura R, Gonzalez A, Evangelista A, Castell J, Margarit C, Esteban R, Guardia J, Genesca J. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005; 42: 68-74
41. Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 2005; 96: 144-147
42. Harley ID, Jones EF, Liu G, McCall PR, McNicol PL. Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy. Br J Anaesth 1996; 77: 675-677
43. Paramesh AS, Fairchild RB, Quinn TM, Leya F, George M, Van Thiel DH. Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation. Liver Transpl 2005; 11: 236-238
44. Goss JA, Stribling R, Martin P. Adult liver transplantation for metabolic liver disease. Clin Liver Dis 1998; 2: 187-210
45. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006; 43: S121-S131
46. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, De Castro S, Merli M. Modiffication of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000; 95: 3200-3205
47. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451-459
48. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002; 26: 842-847
49. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut 2001; 49: 268-275
50. Epstein SK, Ciubotaru RL, Zilberberg MD, Kaplan LM, Jacoby C, Freeman R, Kaplan MM. Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci 1998; 43: 1701-1707
51. Campillo B, Fouet P, Bonnet JC, Atlan G. Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment. J Hepatol 1990; 10: 163-167
52. Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathv. Dig Liver Dis 2007, 39: 507-515
53. Schwartz JM, Beymer C, Althaus SJ, Larson AM, Zaman A, Glickerman DJ, Kowdley KV. Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure. J Clin Gastroenterol 2004; 38: 590-594
54. Bernardi M, Rubboli A, Trevisani F, Cancellieri C, Ligabue A, Baraldini M, Gabarrini G. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. J Hepatol 1991; 12: 207-216
55. Grose RD, Nolan J, Dillon JF, Errington M, Hannan WJ, Bouchier IA, Hayes PC. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol 1995; 22: 326-332
56. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol 2002; 36: 513-520
57. Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int 2003; 23: 243-248
58. Hansen S, Moller S, Bendtsen F, Jensen G, Henriksen JH. Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic change. J Hepatol 2007: 47: 373-380
59. Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest 2005; 115: 2025-2032
60. Brubaker PH, Kitzman DW. Prevalence and management of chronotropic incompetence in heart failure. Curr Cardiol Rep 2007; 9: 229-235
61. Laffi G, Lagi A, Cipriani M, Barletta G, Bernardi L, Fattorini L, Melani L, Riccardi D, Bandinelli G, Mannelli M, La Villa G, Gentilini P. Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. Hepatology 1996; 24: 1063-1067
62. Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats. Am J Physiol 1994; 267: G87-G93